Home › Mesothelioma › California › San Diego
Mesothelioma clinical trials in San Diego, CA
4 studies for Mesothelioma are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- University of California San Diego, La Jolla · 11 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi away
A Beta-only IL-2 ImmunoTherapY Study
RecruitingPhase 1/2
- Sharp Memorial Hospital, San Diego
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- Houston, TX15 studies
- New York City, NY10 studies
- Washington, DC9 studies
- Chicago, IL9 studies
- Boston, MA8 studies
- Nashville, TN8 studies
- Los Angeles, CA6 studies
- Arlington, VA6 studies
- Pittsburgh, PA6 studies
- Philadelphia, PA6 studies
- Seattle, WA6 studies
- Edison, NJ5 studies
Other studies in San Diego
- Non-Small Cell Lung Cancer48 studies
- Breast Cancer41 studies
- Cancer (all types)32 studies
- Prostate Cancer31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer25 studies
- Ovarian Cancer24 studies
- Pancreatic Cancer24 studies
- Lung Cancer23 studies
- Obesity23 studies
- Heart Failure23 studies
- Depression21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.